Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?
01:35pm, Tuesday, 18'th Jul 2023
Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Healthcare Stocks to Buy Amid Market Volatility
09:36am, Thursday, 13'th Jul 2023
Patterson (PDCO), Perrigo (PRGO) and GSK are three healthcare stocks that can lend solidity to one's portfolio today and provide big returns in the foreseeable future.
Why GSK (GSK) is a Top Value Stock for the Long-Term
11:06am, Wednesday, 12'th Jul 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 No-Brainer Stocks to Buy With $50 Right Now
05:21am, Wednesday, 12'th Jul 2023
Although the three major U.S. stock indexes have rebounded from their 2022 bear market lows, bargains can still be found. A relatively small amount of money can go a long way when it's invested in top
How To Find Quality Dividend Stocks With Enduring Core Businesses
07:00am, Monday, 10'th Jul 2023
If a company is going to survive and thrive over many decades, it must focus on what it can do better than its peers. A flywheel may give a company an enduring competitive advantage that widens with e
UK regulator authorizes GSK's RSV vaccine
02:23am, Monday, 10'th Jul 2023
Britain's medicines regulator authorized GSK's vaccine for respiratory syncytial virus (RSV) for older adults, the drugmaker said on Monday.
GSK vs. TECH: Which Stock Is the Better Value Option?
01:05pm, Thursday, 06'th Jul 2023
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with GSK (GSK) and Techne (TECH). But which of these two stocks is more attractive to value investors?
Spero Therapeutics: The Multi-Asset Pipeline Could Outpace The Tebipenem HBr Deal With GSK
03:06pm, Wednesday, 05'th Jul 2023
Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreement with GSK. In addition, Spero has two other ass
GSK-spinoff Haleon exploring sale of Nicotine gum business - Bloomberg News
12:35pm, Monday, 03'rd Jul 2023
Haleon , the world's biggest standalone consumer health business, is exploring the sale of its nicotine gum business as it aims to streamline its business, Bloomberg News reported on Monday, citing pe
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
08:46am, Thursday, 29'th Jun 2023
The CDC said the shots from Pfizer and GSK are expected to be available this fall, when RSV – along with Covid and the flu – begins to spread at higher levels.
US CDC recommends use of new Pfizer, GSK vaccines for RSV in older adults
08:43am, Thursday, 29'th Jun 2023
The director of the U.S. Centers for Disease Control and Prevention (CDC) signed off on Thursday on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infe
Better Artificial Intelligence Stock: GSK or Eli Lilly?
03:15pm, Wednesday, 28'th Jun 2023
Artificial intelligence is being used by the world's top drugmakers to speed up innovation in areas of high unmet medical need. GSK and Eli Lilly are both pioneers in the use of AI for drug discovery
Drugmaker GSK Is Becoming a Healthier Value Stock
11:44am, Tuesday, 27'th Jun 2023
Like most stocks during the dot-com bubble, GSK PLC NYSE: GSK partied like it was 1999. In the two decades since, missteps and competitive pressures slashed roughly 50% from the U.K. pharmaceutical
GSK achieves fast-track Status from US regulator for groundbreaking gonorrhoea vaccine
03:24am, Tuesday, 27'th Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK) has received fast-track designation from the US Food and Drug Administration (FDA) for its experimental vaccine against Neisseria gonorrhoeae, the bacteria causing gonorr
GSK's gonorrhoea vaccine receives FDA's 'fast-track' designation
03:15am, Tuesday, 27'th Jun 2023
GSK's vaccine candidate to treat sexually transmitted infection gonorrhoea has been granted a fast-track designation by the U.S. Food and Drug Administration (FDA), the British drugmaker said on Tuesd
